Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

353.15 -0.78 (-0.22%)
Streaming Delayed Price Updated: 2:07 PM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
64 65 Next >
News headline image
3 Quality Dividend Stocks For A Bear Market ↗
The potential for a recession means investors should focus on quality dividend stocks with strong yields. 
Via Talk Markets
Topics Economy
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today ↗
 
Via Benzinga
News headline image
2 Top Dividend Stocks to Buy in September ↗
These two blue-chip dividend stocks have stood the test of time. 
Via The Motley Fool
News headline image
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in September 2023 ↗
While these undervalued biotech stocks have struggled of late, they could surprise investors and prove to be long-term winners. 
Via InvestorPlace
News headline image
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis ↗
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has  
Via Benzinga
News headline image
How Is The Market Feeling About Amgen? ↗
 
Via Benzinga
News headline image
8 Analysts Have This to Say About Amgen ↗
 
Via Benzinga
News headline image
$1000 Invested In This Stock 15 Years Ago Would Be Worth $4,200 Today ↗
 
Via Benzinga
News headline image
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market ↗
Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However,... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023 ↗
 
Via Benzinga
News headline image
3 Growth Stocks to Buy in September
As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings 
Via MarketBeat
Topics Economy
News headline image
Amgen's Horizon Acquisition Offers Multiple Advantages: Tax Breaks, Shield From Drug Pricing Negotiations ↗
On Friday, the U.S. 
Via Benzinga
News headline image
Should You Still Buy the Dow Jones' Best-Performing August Stocks? ↗
They're rolling now, but this market has been too hot-and-cold of late to ignore any company's -- or company's stock's -- underlying bigger picture. 
Via The Motley Fool
Topics Stocks
News headline image
The 3 Most Promising Dow Stocks to Own Now ↗
The Dow market leaders got their heads handed to them in August. Here are three must-own Dow stocks to own for the long haul. 
Via InvestorPlace
Topics Stocks
News headline image
8 Pharma Stocks Affected by New Drug Price Negotiation Rules ↗
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs? 
Via The Motley Fool
News headline image
Stock Market Rally Gains Momentum As Treasury Yields Slide; Tesla Unveils Model 3 Upgrade: Weekly Review ↗
Tesla unveiled an updated Model 3, but also slashed Model S, X prices. 
Via Investor's Business Daily
News headline image
Amgen-Horizon Therapeutics $28B Acquisition: Federal Trade Commission Gives Green Signal ↗
The U.S. Federal Trade Commission (FTC) has approved drug manufacturer Amgen Inc (NASDAQ: AMGN) to proceed with its $27.8 billion acquisition of Horizon Therapeutics Plc (NASDAQ: HZNP).  
Via Benzinga
News headline image
Amgen, Horizon Therapeutics Stocks Jump After FTC Clears Their $28 Billion Marriage ↗
The deal can now close in the fourth quarter. 
Via Investor's Business Daily
News headline image
Amgen and Horizon Therapeutics plc Resolve FTC Lawsuit, Clearing Path to Close Acquisition
From Horizon Therapeutics plc and Amgen
Via Business Wire
News headline image
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects. 
Via MarketBeat
Topics Economy
News headline image
Is This the Green Light Biotech Stocks Have Been Waiting For? ↗
It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics. 
Via The Motley Fool
News headline image
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks? ↗
Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations. 
Via The Motley Fool
News headline image
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts ↗
To gain an edge, this is what you need to know today. 
Via Benzinga
News headline image
Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle ↗
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including: 
Via Benzinga
News headline image
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts ↗
The Biden administration is planning to negotiate the prices of 10 drugs in 2026. 
Via Investor's Business Daily
News headline image
Nasdaq, S&P 500 Futures Flatline Ahead Of JOLTS, House Price Data; Why This Analyst Recommends 'Buying Weakness Than Selling Rallies' ↗
 
Via Benzinga
Topics Stocks
News headline image
Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories ↗
Reuters 
Via Benzinga
News headline image
Wall Street Thinks This Tiny Biotech Company Could Soar Soon ↗
An upcoming regulatory decision could prove to be an inflection point in the biotech's life cycle. 
Via The Motley Fool
News headline image
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields ↗
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
< Previous 1 2
...
30 31 32 33 34 35 36 37 38
...
64 65 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.